Hercules / Minneapolis / Zurich / Cambridge / Rotkreuz / Basel / Waltham / St. Louis / Santa Cruz / /
Company
Abcam plc / AMS Biotechnology Limited / JAG1 / Roche Diagnostics / Thermo Fisher Scientific / Sigma-Aldrich / Tumor Bank / Ligand / SPOG Tumor Bank / Affymetrix / Qiagen / Cell Signaling Technology / Santa Cruz Biotechnology Inc. / Pearson / Promega Corporation / Swiss Pediatric Oncology Group / Creative Commons / GE Healthcare / BioMed Central Ltd. / Bio-Rad Laboratories Inc. / Sonic / R & D Systems Inc. / /
Country
Switzerland / France / United States / United Kingdom / / /
Event
FDA Phase / /
Facility
Children’s Hospital of Zurich / University Children’s Hospital of Zürich / Duke University / University Children’s Hospital of Zurich / /
IndustryTerm
age / machinery / Probe-primer solutions / /
MedicalCondition
common pediatric malignant brain cancer / MB primary tumors / metastasis / neuroblastoma / human tumors / Grotzer1* Abstract Medulloblastoma / glioblastoma / primary central nervous system neoplasms / leukemia / tumor / cancer / tumors / heterogeneous cerebellar tumors / SHH tumors / aggressive anaplastic tumors / WNT tumors / Medulloblastoma / MB tumor / /
Organization
University Children’s Hospital of Zürich / Ethical Review Board of Zurich / Duke University / Durham / University Children’s Hospital of Zurich / Department of Oncology / /
Person
Henry Friedman / Milton Park / /
Position
player / author / representative / /
Product
Cl / ABI7900HT / /
ProvinceOrState
Minnesota / Manitoba / California / /
Technology
antibodies / siRNA / apoptosis / DNA Chip / Gene expression / ChIP-on-chip / 3g / gel electrophoresis / /
Acta_Neuropathologica_Communications_Logo_Draft_02